this post was submitted on 26 Aug 2024
-30 points (17.4% liked)

Conservative

467 readers
789 users here now

A place to discuss pro-conservative stuff

  1. Be excellent to each other. Civility, No Racism, No Bigotry, No Slurs, No calls to violences, No namecalling, All that good stuff, follow lemm.ee's rules, follow the rules of your instance, etc.

  2. We are a Pro-Conservative forum. Posts must have a clear pro-conservative, or anti left-wing bias. We are interested in promoting conservatism and discussing things that might get ignored elsewhere. All sources are acceptable, however reputable sources with a reputation for factual reporting are preferred.

  3. Dissent is allowed in the comments, but try to be constructive; if you do not agree, then provide a reason which is backed up by references or a reasonable alternative interpretation of the provided facts. That means the left wing is welcome to state their opinions, but please keep it in good faith.

A polite request, not a rule, if you feel the need to report a comment, please don't reply to it.

founded 1 year ago
you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 2 points 6 months ago

Yes. Companies that invest in drugs development deserve to make a profit. Patents protect their investment for a limited amount of time. They should not be able to make unlimited amounts of profit forever. What the drug price controls in Canada do is prevent a company from making a cosmetic change, like adding another stripe to the capsule of Losec, calling is Prilosec, and jacking up the price or increasing by 10 fold the price of an Epipen because you made a minor change to the delivery system. If there isn't a proportionate increase in benefit to the patient you can't raise the price in Canada.